IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise
Shares of GeneDx crashed Wednesday after the company reported adjusted earnings of 28 per share on $87.1 million in first-quarter sales. The post IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise appeared first on Investor's Business Daily.
Shares of GeneDx crashed Wednesday after the company reported adjusted earnings of 28 per share on $87.1 million in first-quarter sales.
The post IBD 50 Stock GeneDx Hammered Despite Earnings Beat-And-Raise appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
